4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001519692-23-000008
Chief Financial Officer sold 649 shares at an average $12.94 ($8,396)
From the SEC's structured data for this filing
Trades in this filing
Greenstein Leonard M. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-17 | Sale : show line 1 in the form | −316 | $13.28 | $4,196 | 33,122 | D |
| 2023-03-20 | Sale : show line 2 in the form | −333 | $12.61 | $4,199 | 32,789 | D |
| Open-market sales · 649 sh · avg $12.94 · $8,396 | ||||||
Loading xslF345X04/wf-form4_167943982457262.xml…